Meike Zeimer

503 total citations
18 papers, 383 citations indexed

About

Meike Zeimer is a scholar working on Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Meike Zeimer has authored 18 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Ophthalmology, 8 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Meike Zeimer's work include Retinal Diseases and Treatments (18 papers), Glaucoma and retinal disorders (10 papers) and Retinal Imaging and Analysis (6 papers). Meike Zeimer is often cited by papers focused on Retinal Diseases and Treatments (18 papers), Glaucoma and retinal disorders (10 papers) and Retinal Imaging and Analysis (6 papers). Meike Zeimer collaborates with scholars based in Germany, United Kingdom and Hungary. Meike Zeimer's co-authors include Daniel Pauleikhoff, B. Heimes, Albrecht Lommatzsch, Georg Spital, Martha Dietzel, Matthias Gutfleisch, Hans‐Werner Hense, Alan C. Bird, Hans W. Hense and H. W. Hense and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, Retina and Eye.

In The Last Decade

Meike Zeimer

18 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meike Zeimer Germany 12 362 225 100 75 16 18 383
Martha Dietzel Germany 13 395 1.1× 263 1.2× 74 0.7× 64 0.9× 8 0.5× 23 431
Tilman Otto United States 7 289 0.8× 151 0.7× 148 1.5× 10 0.1× 12 0.8× 13 324
Rehna Khan United Kingdom 7 382 1.1× 261 1.2× 121 1.2× 7 0.1× 19 1.2× 10 435
S.Y. Cohen France 5 318 0.9× 248 1.1× 46 0.5× 9 0.1× 7 0.4× 19 338
Hajime Bando Japan 9 295 0.8× 205 0.9× 66 0.7× 21 0.3× 6 0.4× 16 332
Lilianne Duarte Portugal 7 534 1.5× 373 1.7× 50 0.5× 7 0.1× 4 0.3× 14 579
Maribel López-Gálvez Spain 5 382 1.1× 296 1.3× 83 0.8× 5 0.1× 5 0.3× 8 434
Emmerson Badaró Brazil 12 346 1.0× 286 1.3× 77 0.8× 9 0.1× 2 0.1× 37 399
Maddalena Quaranta-El Maftouhi France 9 351 1.0× 282 1.3× 28 0.3× 11 0.1× 2 0.1× 13 364
Jonathan Goh Australia 5 309 0.9× 252 1.1× 54 0.5× 5 0.1× 9 0.6× 6 328

Countries citing papers authored by Meike Zeimer

Since Specialization
Citations

This map shows the geographic impact of Meike Zeimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meike Zeimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meike Zeimer more than expected).

Fields of papers citing papers by Meike Zeimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meike Zeimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meike Zeimer. The network helps show where Meike Zeimer may publish in the future.

Co-authorship network of co-authors of Meike Zeimer

This figure shows the co-authorship network connecting the top 25 collaborators of Meike Zeimer. A scholar is included among the top collaborators of Meike Zeimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meike Zeimer. Meike Zeimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sallo, Ferenc B., Irene Leung, Meike Zeimer, et al.. (2017). ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina. 38(1). S79–S88. 17 indexed citations
2.
Dietzel, Martha, et al.. (2016). Changes of macular pigment optical density in elderly eyes: a longitudinal analysis from the MARS study. International Journal of Retina and Vitreous. 2(1). 14–14. 4 indexed citations
4.
Zeimer, Meike, Ferenc B. Sallo, Georg Spital, et al.. (2015). CORRELATION OF OPTICAL COHERENCE TOMOGRAPHY AND MACULAR PIGMENT OPTICAL DENSITY MEASUREMENTS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA. Retina. 36(3). 535–544. 4 indexed citations
5.
Heimes, B., Martha Dietzel, Meike Zeimer, et al.. (2014). Therapiewechsel von Ranibizumab zu Aflibercept bei rezidivierender oder persistierender exsudativer altersbedingter Makuladegeneration. Der Ophthalmologe. 112(5). 435–443. 5 indexed citations
6.
Zeimer, Meike, Georg Spital, B. Heimes, Albrecht Lommatzsch, & Daniel Pauleikhoff. (2013). MACULAR TELANGIECTASIA–CHANGES IN MACULAR PIGMENT OPTICAL DENSITY DURING A 5-YEAR FOLLOW-UP. Retina. 34(5). 920–928. 11 indexed citations
7.
Zeimer, Meike, et al.. (2012). Profiles of Macular Pigment Optical Density and Their Changes Following Supplemental Lutein and Zeaxanthin: New Results from the LUNA Study. Investigative Ophthalmology & Visual Science. 53(8). 4852–4852. 21 indexed citations
8.
Heimes, B., Albrecht Lommatzsch, Meike Zeimer, et al.. (2011). Anti-VEGF-Therapie der exsudativen AMD: Prognostische Faktoren für den Therapieerfolg. Der Ophthalmologe. 108(2). 124–131. 1 indexed citations
9.
Dietzel, Martha, et al.. (2011). Determinants of Macular Pigment Optical Density and Its Relation to Age-Related Maculopathy: Results from the Muenster Aging and Retina Study (MARS). Investigative Ophthalmology & Visual Science. 52(6). 3452–3452. 42 indexed citations
10.
Dietzel, Martha, Meike Zeimer, B. Heimes, Daniel Pauleikhoff, & Hans‐Werner Hense. (2011). The Ringlike Structure of Macular Pigment in Age-Related Maculopathy: Results from the Muenster Aging and Retina Study (MARS). Investigative Ophthalmology & Visual Science. 52(11). 8016–8016. 34 indexed citations
11.
Zeimer, Meike, et al.. (2010). MACULAR TELANGIECTASIA. Retina. 30(8). 1282–1293. 37 indexed citations
12.
Heimes, B., Albrecht Lommatzsch, Meike Zeimer, et al.. (2010). Anti-VEGF-Therapie der exsudativen AMD. Der Ophthalmologe. 108(2). 124–131. 6 indexed citations
13.
Zeimer, Meike, et al.. (2010). IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2: DISTRIBUTION OF MACULAR PIGMENT AND FUNCTIONAL INVESTIGATIONS. Retina. 30(4). 586–595. 45 indexed citations
14.
Heimes, B., Albrecht Lommatzsch, Meike Zeimer, et al.. (2010). Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection scheme. Graefe s Archive for Clinical and Experimental Ophthalmology. 249(5). 639–644. 38 indexed citations
15.
Lommatzsch, Albrecht, B. Heimes, Matthias Gutfleisch, et al.. (2009). Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye. 23(12). 2163–2168. 53 indexed citations
17.
Heimes, B., Albrecht Lommatzsch, Meike Zeimer, et al.. (2008). Foveal RPE autofluorescence as a prognostic factor for anti-VEGF therapy in exudative AMD. Graefe s Archive for Clinical and Experimental Ophthalmology. 246(9). 1229–1234. 18 indexed citations
18.
Lommatzsch, Albrecht, B. Heimes, Matthias Gutfleisch, et al.. (2008). Die Therapie der vaskularisierten serösen Pigmentepithelabhebung bei AMD – Beobachtungen nach Wechsel des intravitrealen Medikamentes bei Therapieversagen. Klinische Monatsblätter für Augenheilkunde. 225(10). 874–879. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026